Biological E to infuse over Rs 1800 crore to ramp up production of vaccines, injectables, RnD

The investment from Biological E will enhance the capacity by five billion doses increasing the cumulative capacity to about 14 billion doses each year.

Published On 2022-07-23 08:45 GMT   |   Update On 2022-07-23 08:45 GMT
Advertisement

Hyderabad: Vaccine maker Biological E on Thursday announced its expansion plans for investment of over Rs 1,800 crore, which will generate employment of more than 2500 people in their three facilities in Genome Valley here.

According to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines along with generic Injectables and R&D.

Advertisement

The announcement was made after IT and Industries Minister KT Rama Rao's meeting with leadership of Biological E Mahima Datla, Managing Director.

Rama Rao said, "I'm delighted to announce the expansion plans of Biological E in Genome Valley. Hyderabad is already known as the "vaccine Capital of the World" and this expansion further accelerates our strength to serve the world with live saving vaccines."

The investment from Biological E will enhance the capacity by five billion doses increasing the cumulative capacity to about 14 billion doses each year.

Read also: WHO gives nod to Biological E as additional production site for JnJ COVID vaccine

Mahima Datla, Managing Director of Biological E has said, "I'm thankful to the government of Telangana, the vision of Honourable Chief Minister K Chandrashekar Rao and Honourable Minister K T Rama Rao for spearheading and continuing to facilitate in a way that enables us to take quick decisions to expand even during the pandemic times."

Currently, BE has four strategic business units- Branded Formulations, Specialty Generic Injectables, Synthetic Biology and Vaccines and Biologics in Telangana with six manufacturing facilities and creating direct employment for more than 5,000 people.

Read also: NTAGI panel reviews data for Biological E Corbevax as booster for Covishield, Covaxin recipients

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News